Results 51 to 60 of about 5,956,077 (339)

Observational multicenter study of efficacy of paroxetine film-coated tablet in the treatment of anxiety disorder [PDF]

open access: yesMedicinski Glasnik, 2018
Aim To examine the efficiency of paroxetine treatment of anxiety disorders in adult patients over the period of 12 months and the improvement of symptoms of anxiety disorder during this period, as well as to examine the tolerability of the administered ...
Alma Džubur Kulenović   +7 more
doaj   +1 more source

Tolerability of Antimalaria Drugs [PDF]

open access: yesClinical Infectious Diseases, 2002
Sir—The multicenter randomized trial reported by Overbosch and colleagues [1] is important for 2 reasons. First, the study shows that when taken as malaria prophylaxis, mefloquine is not well tolerated by many travelers. Of the study participants randomized to receive mefloquine, 67.1% reported 1 adverse event, and, in 6% of mefloquine users, these ...
Ashley M. Croft, Andrew Herxheimer
openaire   +1 more source

Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer. [PDF]

open access: yes, 2019
Although targeted therapies often elicit profound initial patient responses, these effects are transient due to residual disease leading to acquired resistance.
A Hübner   +66 more
core   +1 more source

mGluR5 Negative Modulators for Fragile X: Treatment Resistance and Persistence

open access: yesFrontiers in Psychiatry, 2021
Fragile X syndrome (FXS) is caused by silencing of the human FMR1 gene and is the leading monogenic cause of intellectual disability and autism. Abundant preclinical data indicated that negative allosteric modulators (NAMs) of metabotropic glutamate ...
David C. Stoppel   +4 more
doaj   +1 more source

Post-mortem toxicology: A pilot study to evaluate the use of a Bayesian network to assess the likelihood of fatality [PDF]

open access: yes, 2015
The challenge of interpreting post-mortem drug concentrations is well documented and relies on appropriate sample collection, knowledge of case circumstances as well as reference to published tables of data, whilst taking into account the known issues of
Bolton, Jennifer   +3 more
core   +1 more source

Hsp21potentiates antifungal drug tolerance in Candida albicans [PDF]

open access: yes, 2013
Peer reviewedPublisher ...
Alix Therese Coste   +52 more
core   +2 more sources

Efficacy of β-lactam/β-lactamase inhibitor combination is linked to WhiB4-mediated changes in redox physiology of Mycobacterium tuberculosis

open access: yeseLife, 2017
Mycobacterium tuberculosis (Mtb) expresses a broad-spectrum β-lactamase (BlaC) that mediates resistance to one of the highly effective antibacterials, β-lactams.
Saurabh Mishra   +10 more
doaj   +1 more source

Comparison of Different Clinical Chemotherapeutical Agents’ Toxicity and Cell Response on Mesenchymal Stem Cells and Cancer Cells

open access: yesCells, 2022
Mesenchymal stem cells (MSCs) or fibroblasts are one of the most abundant cell types in the tumor microenvironment (TME) exerting various anti- and pro-apoptotic effects during tumorigenesis, invasion, and drug treatment.
Flóra Vajda   +9 more
doaj   +1 more source

Volumetric fluid analysis of fixed monthly anti-VEGF treatment in patients with neovascular age-related macular degeneration [PDF]

open access: yesInternational Journal of Ophthalmology, 2023
AIM: To evaluate visual outcomes and changes in fluid after administering monthly anti-vascular endothelial growth factor (VEGF) injections to treat neovascular age-related macular degeneration (nAMD) with subretinal fluid (SRF) and pigment epithelial ...
Bo Hee Kim   +3 more
doaj   +1 more source

Characterization of HSP90 isoforms in transformed bovine leukocytes infected with Theileria annulata [PDF]

open access: yes, 2016
HSP90 chaperones are essential regulators of cellular function, as they ensure the appropriate conformation of multiple key client proteins. Four HSP90 isoforms were identified in the protozoan parasite Theileria annulata.
Calder, Ewen D.D.   +8 more
core   +2 more sources

Home - About - Disclaimer - Privacy